Neuropace (NPCE): CFO bought ~$99K
Patrick F. Williams, CFO at Neuropace, bought ~$99K of Neuropace shares.
- ~$99K
- Approx. value · 12K sh @ $8.34
- 79K
- Holds after · shares reported
- Traded
- Nov 17, 2026
- Filed
- Nov 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 17, 2025Federal contract · $37K obligatedDepartment of Veterans Affairs awarded NeuroPace Inc: $37K obligated to date
- Nov 12, 2026Company filing · Form 8-K · ResultsReported its results
- Nov 17, 2026 · this disclosureInsider · First insider buy since Nov 2022CFO purchased ~$99K of NPCE shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Neuropace
For Neuropace, OQRO holds 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NPCE page.
How this filing works
Explore the data
Common questions
Which Neuropace (NPCE) insider traded, and how much?
Patrick F. Williams, CFO at Neuropace, bought ~$99K of Neuropace shares. 12K shares at $8.34, open market.
When did it happen, and when was it made public?
Traded: Nov 17, 2026. Filed: Nov 17, 2026.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Neuropace recently?
For Neuropace, OQRO holds 1 federal contract award dated in the last 90 days. They are listed on the NPCE page.
Does this mean NPCE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Neuropace
- USAspending.gov award recordOct 5, 2026
- SEC Form 13F-HRAug 14, 2026
- USAspending.gov award recordJun 9, 2026
- SEC Form 13F-HRMay 15, 2026
- USAspending.gov award recordMar 17, 2026
- USAspending.gov award recordMar 11, 2026
Everything OQRO holds on this company is on its NPCE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data